Cargando…

Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3

Kleresca® biophotonic platform utilizing fluorescent light energy effectively decreased the inflammatory and erythematous reaction common in rosacea subtypes 1, 2, and 3. Kleresca® may be considered as a single treatment for rosacea, targeting multiple features, or combined with invasive methods for...

Descripción completa

Detalles Bibliográficos
Autores principales: Sannino, Mario, Lodi, Giuseppe, Dethlefsen, Markus Wied, Nisticò, Steven Paul, Cannarozzo, Giovanni, Nielsen, Michael Canova Engelbrecht
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293188/
https://www.ncbi.nlm.nih.gov/pubmed/30564333
http://dx.doi.org/10.1002/ccr3.1891
_version_ 1783380503466868736
author Sannino, Mario
Lodi, Giuseppe
Dethlefsen, Markus Wied
Nisticò, Steven Paul
Cannarozzo, Giovanni
Nielsen, Michael Canova Engelbrecht
author_facet Sannino, Mario
Lodi, Giuseppe
Dethlefsen, Markus Wied
Nisticò, Steven Paul
Cannarozzo, Giovanni
Nielsen, Michael Canova Engelbrecht
author_sort Sannino, Mario
collection PubMed
description Kleresca® biophotonic platform utilizing fluorescent light energy effectively decreased the inflammatory and erythematous reaction common in rosacea subtypes 1, 2, and 3. Kleresca® may be considered as a single treatment for rosacea, targeting multiple features, or combined with invasive methods for an enhanced normalizing and healing profile of the skin.
format Online
Article
Text
id pubmed-6293188
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-62931882018-12-18 Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3 Sannino, Mario Lodi, Giuseppe Dethlefsen, Markus Wied Nisticò, Steven Paul Cannarozzo, Giovanni Nielsen, Michael Canova Engelbrecht Clin Case Rep Case Reports Kleresca® biophotonic platform utilizing fluorescent light energy effectively decreased the inflammatory and erythematous reaction common in rosacea subtypes 1, 2, and 3. Kleresca® may be considered as a single treatment for rosacea, targeting multiple features, or combined with invasive methods for an enhanced normalizing and healing profile of the skin. John Wiley and Sons Inc. 2018-10-25 /pmc/articles/PMC6293188/ /pubmed/30564333 http://dx.doi.org/10.1002/ccr3.1891 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Sannino, Mario
Lodi, Giuseppe
Dethlefsen, Markus Wied
Nisticò, Steven Paul
Cannarozzo, Giovanni
Nielsen, Michael Canova Engelbrecht
Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3
title Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3
title_full Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3
title_fullStr Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3
title_full_unstemmed Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3
title_short Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3
title_sort fluorescent light energy: treating rosacea subtypes 1, 2, and 3
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293188/
https://www.ncbi.nlm.nih.gov/pubmed/30564333
http://dx.doi.org/10.1002/ccr3.1891
work_keys_str_mv AT sanninomario fluorescentlightenergytreatingrosaceasubtypes12and3
AT lodigiuseppe fluorescentlightenergytreatingrosaceasubtypes12and3
AT dethlefsenmarkuswied fluorescentlightenergytreatingrosaceasubtypes12and3
AT nisticostevenpaul fluorescentlightenergytreatingrosaceasubtypes12and3
AT cannarozzogiovanni fluorescentlightenergytreatingrosaceasubtypes12and3
AT nielsenmichaelcanovaengelbrecht fluorescentlightenergytreatingrosaceasubtypes12and3